These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 15790955)

  • 1. Liver x receptor agonists inhibit cytokine-induced osteopontin expression in macrophages through interference with activator protein-1 signaling pathways.
    Ogawa D; Stone JF; Takata Y; Blaschke F; Chu VH; Towler DA; Law RE; Hsueh WA; Bruemmer D
    Circ Res; 2005 Apr; 96(7):e59-67. PubMed ID: 15790955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nuclear receptor corepressor-dependent pathway mediates suppression of cytokine-induced C-reactive protein gene expression by liver X receptor.
    Blaschke F; Takata Y; Caglayan E; Collins A; Tontonoz P; Hsueh WA; Tangirala RK
    Circ Res; 2006 Dec; 99(12):e88-99. PubMed ID: 17110595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPARalpha agonists suppress osteopontin expression in macrophages and decrease plasma levels in patients with type 2 diabetes.
    Nakamachi T; Nomiyama T; Gizard F; Heywood EB; Jones KL; Zhao Y; Fuentes L; Takebayashi K; Aso Y; Staels B; Inukai T; Bruemmer D
    Diabetes; 2007 Jun; 56(6):1662-70. PubMed ID: 17360982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AP-1 is involved in UTP-induced osteopontin expression in arterial smooth muscle cells.
    Renault MA; Jalvy S; Belloc I; Pasquet S; Sena S; Olive M; Desgranges C; Gadeau AP
    Circ Res; 2003 Oct; 93(7):674-81. PubMed ID: 12970113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries.
    Blaschke F; Leppanen O; Takata Y; Caglayan E; Liu J; Fishbein MC; Kappert K; Nakayama KI; Collins AR; Fleck E; Hsueh WA; Law RE; Bruemmer D
    Circ Res; 2004 Dec; 95(12):e110-23. PubMed ID: 15539633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver X receptor agonists inhibit tissue factor expression in macrophages.
    Terasaka N; Hiroshima A; Ariga A; Honzumi S; Koieyama T; Inaba T; Fujiwara T
    FEBS J; 2005 Mar; 272(6):1546-56. PubMed ID: 15752369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopontin transcription in aortic vascular smooth muscle cells is controlled by glucose-regulated upstream stimulatory factor and activator protein-1 activities.
    Bidder M; Shao JS; Charlton-Kachigian N; Loewy AP; Semenkovich CF; Towler DA
    J Biol Chem; 2002 Nov; 277(46):44485-96. PubMed ID: 12200434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver X receptor activation potentiates the lipopolysaccharide response in human macrophages.
    Fontaine C; Rigamonti E; Nohara A; Gervois P; Teissier E; Fruchart JC; Staels B; Chinetti-Gbaguidi G
    Circ Res; 2007 Jul; 101(1):40-9. PubMed ID: 17540978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPARgamma ligand inhibits osteopontin gene expression through interference with binding of nuclear factors to A/T-rich sequence in THP-1 cells.
    Oyama Y; Akuzawa N; Nagai R; Kurabayashi M
    Circ Res; 2002 Feb; 90(3):348-55. PubMed ID: 11861425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UTP induces osteopontin expression through a coordinate action of NFkappaB, activator protein-1, and upstream stimulatory factor in arterial smooth muscle cells.
    Renault MA; Jalvy S; Potier M; Belloc I; Genot E; Dekker LV; Desgranges C; Gadeau AP
    J Biol Chem; 2005 Jan; 280(4):2708-13. PubMed ID: 15557322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver X receptor-alpha gene expression is positively regulated by thyroid hormone.
    Hashimoto K; Matsumoto S; Yamada M; Satoh T; Mori M
    Endocrinology; 2007 Oct; 148(10):4667-75. PubMed ID: 17628006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions.
    Laffitte BA; Joseph SB; Chen M; Castrillo A; Repa J; Wilpitz D; Mangelsdorf D; Tontonoz P
    Mol Cell Biol; 2003 Mar; 23(6):2182-91. PubMed ID: 12612088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of liver X receptor attenuates endothelin-1 expression in vascular endothelial cells.
    Gao M; Zeng Y; Guan Y; Hu Z; Zhong D; Shen X; Zhang L; Xu Z; Gong W; Zhang Y; Zhang M; Zheng Y; He F
    Int J Biochem Cell Biol; 2012 Dec; 44(12):2299-307. PubMed ID: 23018104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages.
    Castrillo A; Joseph SB; Marathe C; Mangelsdorf DJ; Tontonoz P
    J Biol Chem; 2003 Mar; 278(12):10443-9. PubMed ID: 12531895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteopontin in rat renal fibroblasts: functional properties and transcriptional regulation by aldosterone.
    Irita J; Okura T; Kurata M; Miyoshi K; Fukuoka T; Higaki J
    Hypertension; 2008 Feb; 51(2):507-13. PubMed ID: 18158341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoregulation of the human liver X receptor alpha promoter.
    Laffitte BA; Joseph SB; Walczak R; Pei L; Wilpitz DC; Collins JL; Tontonoz P
    Mol Cell Biol; 2001 Nov; 21(22):7558-68. PubMed ID: 11604492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription of the vascular endothelial growth factor gene in macrophages is regulated by liver X receptors.
    Walczak R; Joseph SB; Laffitte BA; Castrillo A; Pei L; Tontonoz P
    J Biol Chem; 2004 Mar; 279(11):9905-11. PubMed ID: 14699103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional regulation of human osteopontin promoter by C/EBPalpha and AML-1 in metastatic cancer cells.
    Liu YN; Kang BB; Chen JH
    Oncogene; 2004 Jan; 23(1):278-88. PubMed ID: 14712233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reciprocal negative cross-talk between liver X receptors (LXRs) and STAT1: effects on IFN-γ-induced inflammatory responses and LXR-dependent gene expression.
    Pascual-García M; Rué L; León T; Julve J; Carbó JM; Matalonga J; Auer H; Celada A; Escolà-Gil JC; Steffensen KR; Pérez-Navarro E; Valledor AF
    J Immunol; 2013 Jun; 190(12):6520-32. PubMed ID: 23686490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel role for c-Jun N-terminal kinase and phosphoinositide 3-kinase in the liver X receptor-mediated induction of macrophage gene expression.
    Huwait EA; Greenow KR; Singh NN; Ramji DP
    Cell Signal; 2011 Mar; 23(3):542-9. PubMed ID: 21070853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.